Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
7.RaglanO.,KallialaI.,MarkozannesG.iwsp.Riskfactorsforendometrialcancer:Anum-
brellareviewoftheliterature.IntJCancer.2019;145:1719-1730,https://doi.org/10.1002/
IJC.31961.
8.LuoJ.,BeresfordS.,ChenC.iwsp.Associationbetweendiabetes,diabetestreatmentand
riskofdevelopingendometrialcancer.BrJCancer.2014;111:1432,https://doi.org/10.1038/
BJC.2014.407.
9.IgnatovA.,OrtmannO.Endocrineriskfactorsofendometrialcancer:Polycysticovarysyn-
drome,oralcontraceptives,infertility,tamoxifen.Cancers(Basel).2020;12:1-10,https://
doi.org/10.3390/CANCERS12071766.
10.JordanS.J.,NaR.,JohnattyS.E.iwsp.Breastfeedingandendometrialcancerrisk:Ananaly-
sisfromtheepidemiologyofendometrialcancerconsortium.ObstetGynecol.2017;129:
1059-1067,https://doi.org/10.1097/AOG.0000000000002057.
11.CoteM.L.,AlhajjT.,RuterbuschJ.J.iwsp.Riskfactorsforendometrialcancerinblackand
whitewomen:ApooledanalysisfromtheEpidemiologyofEndometrialCancerConsor-
tium(E2C2).CancerCausesControl.2015;26:287-296,https://doi.org/10.1007/S10552-
014-0510-3.
12.SwerdlowA.J.,JonesM.E.,BrewsterD.H.iwsp.Tamoxifentreatmentforbreastcancerand
riskofendometrialcancer:Acase-controlstudy.JNatlCancerInst.2005;97:375-384,
https://doi.org/10.1093/JNCI/DJI057.
13.BeralV.,BullD.,ReevesG.Endometrialcancerandhormone-replacementtherapyin
theMillionWomenStudy.Lancet.2005;365:1543-1551,https://doi.org/10.1016/S0140-
6736(05)66455-0.
14.SchmidD.,BehrensG.,KeimlingM.iwsp.Asystematicreviewandmeta-analysisofphy-
sicalactivityandendometrialcancerrisk.EurJEpidemiol.2015;30:397-412,https://doi.
org/10.1007/S10654-015-0017-6.
15.RuanX.,MueckA.O.Impactofsmokingonestrogenicefcacy.Climacteric.2015;18:38-46,
https://doi.org/10.3109/13697137.2014.929106.
16.MeyerL.A.,BroaddusR.R.,LuK.H.EndometrialcancerandLynchsyndrome:Clini-
calandpathologicconsiderations.CancerControl.2009;16:14,https://doi.org/10.1177/
107327480901600103.
17.WuY.,SunW.,LiuH.,ZhangD.Ageatmenopauseandriskofdevelopingendometrial
cancer:Ameta-analysis2019,https://doi.org/10.1155/2019/8584130.
18.BarryJ.A.,AziziaM.M.,HardimanP.J.Riskofendometrial,ovarianandbreastcancerinwo-
menwithpolycysticovarysyndrome:Asystematicreviewandmeta-analysis.HumReprod
Update.2014;20:748-758,https://doi.org/10.1093/humupd/dmu012.
19.BokhmanJ.V
.Twopathogenetictypesofendometrialcarcinoma.GynecolOncol.1983;15:
10-17,https://doi.org/10.1016/0090-8258(83)90111-7.
20.SetiawanV.W.,YangH.P.,PikeM.C.iwsp.TypeIandIIendometrialcancers:Have
theydiferentriskfactors?JClinOncol.2013;31:2607-2618,https://doi.org/10.1200/
JCO.2012.48.2596.